Lipopolysaccharides Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global Lipopolysaccharides (LPS) Immunoassay market has witnessed substantial growth, with worldwide revenue reaching US$ 1.45 billion at the close of 2024. According to a comprehensive report by Fairfield Market Research, the market is expected to continue its upward trajectory. By the end of 2031, the market is projected to reach US$ 1.9 billion.
Opportunities for Manufacturers:
• LPS Detection through Point-of-Care Testing: The market for LPS immunoassays is set for growth driven by the development of point-of-care test kits. This approach finds applications in various industries, including dentistry, where it aids in diagnosing periodontal disease, gum disease, and tooth loss. LPS detection is also crucial for overall body health, with potential links to conditions like cardiovascular and neurodegenerative diseases. The emergence of infectious diseases further fuels the demand for LPS detection, making point-of-care technology a promising avenue for growth.
Challenges Affecting Demand:
• Lack of Identified Library for Lipopolysaccharides: The absence of screening assays for multiple LPS antigens limits their use in detection, affecting the accessibility of specific antibodies. Techniques for selecting tailored antibodies need enhancement, and the availability of alternate LPS detection methods hampers market growth.
Country-wise Insights:
• U.S. Market: The U.S. LPS immunoassay market is lucrative due to advanced diagnostics availability and rising demand driven by an increase in cancer cases and infectious diseases, including HIV, TB, and influenza.
• Germany: Germany's biopharmaceutical industry fuels demand for LPS immunoassays, as established players conduct clinical studies to evaluate biopharmaceutical products for human use.
• China: With a large population base, China shows high growth potential in the sales of LPS immunoassay products, driven by the need for efficient infectious disease diagnosis, particularly in response to novel coronavirus infections.
Competitive Landscape:
Major companies in the LPS immunoassay market are actively involved in strategic activities, including mergers and acquisitions, innovative product development, and geographical expansion, to meet the evolving needs of patients.
Key Companies Profiled:
• BioChek (BIOTECON Diagnostics)
• AdVnt Biotechnologies
• Fisher Scientific (THERMO)
• Bio-Techne
• Response Biomedical
• New Horizons Diagnostic Corporation
Key Segments of Lipopolysaccharides Immunoassay Industry Research
Lipopolysaccharides Immunoassay Market by Product Type:
• Immunoassay Kits & Reagents
Kits
Primary Antibodies
Secondary Antibodies
Immunoassay Substrates
Immunoassay Buffers
• Analysers & Instruments
• Consumables
• Software
Lipopolysaccharides Immunoassay Market by Assay:
• ELISA
• FIA
• CLIA
• LFA
• Others
Lipopolysaccharides Immunoassay Market by Purpose:
• Research Use Only
• Clinical Use
Lipopolysaccharides Immunoassay Market by Application:
• Clinical Diagnostics
• Drug Discovery
• Screening of diseases & disorders
Lipopolysaccharides Immunoassay Market by End User:
• Human Use
• Veterinary
Lipopolysaccharides Immunoassay Market by Region:
• North America Lipopolysaccharides Immunoassay Market
• Latin America Lipopolysaccharides Immunoassay Market
• Europe Lipopolysaccharides Immunoassay Market
• South Asia Lipopolysaccharides Immunoassay Market
• East Asia Lipopolysaccharides Immunoassay Market
• Oceania Lipopolysaccharides Immunoassay Market
• The Middle East & Africa Lipopolysaccharides Immunoassay Market
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.